DEVIN WELKER: Open Payments
NPI 1255976858 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 33 payments from 20 companies in 2025. Trend: 2023 $620 · 2024 $769 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $82 |
| Radius Health, Inc. | 2 | $66 |
| Novo Nordisk Inc | 3 | $65 |
| Amgen Inc. | 3 | $56 |
| Insulet Corporation | 2 | $50 |
| Tandem Diabetes Care, Inc. | 2 | $50 |
| Alexion Pharmaceuticals, Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| CeQur Corporation | 1 | $36 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $34 |
Products named: Tymlos, Omnipod, t:slim X2 Insulin Pump with Control-IQ, STRENSIQ, Ozempic, JARDIANCE, FARXIGA, EVENITY.
Industry payments across AZ — which companies pay providers there.
